Comparison · Method
INUSpheresis vs plasma exchange
Both are apheresis and both are sold for "cleaning the blood", but they do different things to your plasma. Here they are side by side.
Updated Nov 17, 2026
The difference in one paragraph
| Plasma exchange (TPE) | INUSpheresis | |
|---|---|---|
| What happens to your plasma | Removed and discarded | Filtered and returned |
| Replacement fluid | Yes, usually 5% albumin (sometimes saline or donor plasma) | None needed |
| What is lowered | Everything carried in plasma, roughly in proportion to the volume exchanged | What the chosen secondary filter retains |
| Typical session | About 90 minutes to 4 hours (clinic figures) | About 2 to 3 hours (center figures) |
| Typical course | Varies by clinic; listed series of 2 to 6 | Usually two treatments a few days apart to start |
| Equipment | Centrifugal or membrane apheresis machines, e.g. Terumo Spectra Optia (FDA-cleared device) | Ayus/INUS filtration system, e.g. IN-300 with named filters |
| Established medical uses | Many, graded disease by disease by ASFA | Used as lipoprotein apheresis for familial hypercholesterolaemia (e.g. Cromwell Hospital); detox and longevity uses are not established |
| Longevity or detox evidence | Small trials measuring biomarkers; one negative long COVID trial | Preliminary reports, often by company-affiliated authors |
| Available in the US | Yes, at hospitals and private clinics | No US center in the manufacturer's finder |
| Listed private prices | About $3,500 to $12,000 per session | About €2,900 per treatment; €5,400–€5,700 for a two-treatment course |
How does each method handle plasma?
In plasma exchange, plasma is separated from blood cells, discarded and replaced[4]. In INUSpheresis, a primary filter separates the plasma, a secondary filter adapted to the treatment goal removes target substances, and the plasma is returned[1]. Ayus states that INUSpheresis is not a plasma exchange[1], and INUS Medical Center describes it as double filtration plasmapheresis with no plasma lost[2].
Is one more evidence-based than the other?
For established diseases, plasma exchange has far more evidence, graded indication by indication by the American Society for Apheresis. For longevity and detox, both are early. The strongest TPE longevity study is a 42-person randomized trial that measured epigenetic clocks, not health outcomes[6]; AMBAR studied Alzheimer's disease, not healthy people[7]; and a placebo-controlled long COVID trial found no benefit[8]. For filtration, the published toxin data are preliminary and several authors are affiliated with the manufacturer[10]. A 2026 TPE study measured falls in circulating microplastics[9]; nobody has yet shown that lowering them improves health.
Which one should I choose?
That is a decision for you and a physician who knows your history. Practical differences can help frame the conversation: plasma exchange can be done at 8 providers listed on Northvane, most of them in the US; INUSpheresis at 8 centers in Europe, with no US center yet. Plasma exchange lowers antibodies and proteins broadly, which is the point for some diseases and a risk to discuss for others. INUSpheresis returns your own plasma, but what it removes depends on filters each center chooses.
Sources
- [1]Blood Plasma Purification Therapy: Treatment process · Ayus Medical Group (Inuspheresis Center Basel) · 2026 · read Nov 17, 2026
- [2]INUS Medical Center · INUS Medical Center AG · 2026 · read Nov 17, 2026
- [3]Find Your Inuspheresis® Center · Ayus Medical Devices AG (manufacturer) · 2026 · read Nov 17, 2026
- [4]Plasma Exchange (Plasmapheresis) · American College of Rheumatology patient information (written July 2025) · 2025 · read Nov 17, 2026
- [5]510(k) K071079: Spectra Optia Apheresis System (product code LKN, therapeutic blood cell and plasma separator) · U.S. Food and Drug Administration 510(k) database · 2007 · read Nov 17, 2026
- [6]Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Single-Blinded Randomized Placebo-Controlled Therapeutic Plasma Exchange · Aging Cell 24(8):e70103, Fuentealba M, Kiprov D, et al. PMID 40424097 · 2025 · read Nov 17, 2026
- [7]A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study · Alzheimer's & Dementia 16(10):1412-1425, Boada M et al. PMID 32715623 · 2020 · read Nov 17, 2026
- [8]Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial · Nature Communications 16:1929, España-Cueto S et al. PMID 39994269 · 2025 · read Nov 17, 2026
- [9]Can Plasma Exchange Be Used to Lower the Circulating Burden of Microplastics in Human Patients? · Journal of Clinical Apheresis 41(3):e70135, Weinstein R et al. PMID 42169439 · 2026 · read Nov 17, 2026
- [10]Therapeutic apheresis: An effective strategy for a combined targeting of circulating lipoproteins, inflammatory markers, PFAS, and microplastics? · Brain Health (online ahead of print), Bornstein SR et al. PMID 42985345 · 2026 · read Nov 17, 2026